Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in Healthcare
November 08 2017 - 9:00AM
Business Wire
Illumina, Inc. (NASDAQ: ILMN) announced today that Gary S.
Guthart will join the company’s Board of Directors on December 1,
2017. Dr. Guthart is President and Chief Executive Officer of
Intuitive Surgical, a global leader in the field of
robotic-assisted minimally invasive surgery.
This press release features multimedia. View
the full release here:
http://www.businesswire.com/news/home/20171108005548/en/
Gary Guthart (Photo: Business Wire)
Dr. Guthart joined Intuitive Surgical in April 1996 and has
served as the Chief Executive Officer since January 2010. In July
2007, he was promoted to President, having assumed the role of
Chief Operating Officer in February 2006. Prior to joining
Intuitive Surgical, he was part of the core team developing the
foundational technology for computer-enhanced surgery at SRI
International (formerly Stanford Research Institute). Dr. Guthart
served as a member of the Board of Directors of Affymetrix, Inc.
from May 2009 until its acquisition by Thermo Fisher Scientific
Inc. in March 2016.
“Gary is a talented leader who adds a tremendous breadth of
industry knowledge and experience to our exceptional board of
directors,” said Francis deSouza, Illumina President and Chief
Executive Officer. “He will bring leadership, strategy and policy
expertise in the healthcare sector as Illumina continues to drive
adoption of genomics in clinical markets.”
Dr. Guthart received a B.S. in Engineering from the University
of California, Berkeley and an M.S. and a Ph.D. in Engineering
Science from the California Institute of Technology.
About Illumina
Illumina is improving human health by unlocking the power
of the genome. Our focus on innovation has established us as the
global leader in DNA sequencing and array-based technologies,
serving customers in the research, clinical and applied markets.
Our products are used for applications in the life sciences,
oncology, reproductive health, agriculture, and other emerging
segments. To learn more, visit www.illumina.com and
follow @illumina.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171108005548/en/
Illumina, Inc.Investors:Jacquie Ross,
CFA858-255-5243IR@illumina.comorMedia:Eric
Endicott858-882-6822pr@illumina.com
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Sep 2023 to Sep 2024